| 1 |
2008 |
Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. |
IL-2 |
| 2 |
2008 |
IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes. |
--- |
| 3 |
2008 |
Measurement of human and murine interleukin 2 and interleukin 4. |
IL-2, IL-4, MTT |
| 4 |
2008 |
Preparing T cell growth factor from rat splenocytes. |
--- |
| 5 |
2008 |
Technique for culturing Macaca mulatta peripheral blood lymphocytes for fluorescence in situ hybridization of whole chromosome paints. |
Con A, PHA, SEA |
| 6 |
2006 |
[Discovery of immature thymocyte proliferation factor]. |
NPF |
| 7 |
2004 |
The quantal theory of how the immune system discriminates between "self and non-self" |
IL-2, IL-2R, TCR |
| 8 |
2003 |
Isolation of proliferation factor of immature T-cell clone in concanavalin A-stimulated splenocyte culture supernatant. |
mrH, NPF |
| 9 |
2001 |
An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. |
--- |
| 10 |
2000 |
Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. |
--- |
| 11 |
1998 |
Characterization of phenotype related responsiveness of peripheral blood lymphocytes from Eimeria tenella infected chickens. |
MoAb |
| 12 |
1997 |
Development of a highly quantitative, reproducible assay for determination of chicken T cell growth factor biological activity. |
DMEM, OD, RPMI |
| 13 |
1996 |
T cell responses to Mycobacterium bovis in red deer, a large animal model for tuberculosis. |
BCG |
| 14 |
1995 |
Absence of high-affinity binding sites for interferon alpha/beta in variant murine CD4+ T lymphocytes not expressing the T cell antigen receptor. |
IFN |
| 15 |
1995 |
Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. |
--- |
| 16 |
1994 |
Impairment of T-cell growth-promoting lymphokines in human insulin-dependent diabetes mellitus. |
PBMC, PHA, SI |
| 17 |
1994 |
Production of cytokines by lymphocytes from spleen, mesenteric lymph node and intestinal lamina propria of pigs. |
IL-2R, PCR |
| 18 |
1994 |
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. |
MC, PCR, PTEC |
| 19 |
1994 |
Thy.1lowCD3- cells sorted from nylon wool-passed bone marrow cells can augment the H-2 identical but not non-identical cytotoxic T lymphocyte precursors in mixed lymphocyte cultures. |
CTL, LN, NW-BM, self-MHC, Th |
| 20 |
1993 |
A multigene family on human chromosome 12 encodes natural killer-cell lectins. |
NK, RFLP |
| 21 |
1993 |
Effect of physical exhaustion and glucocorticoids (dexamethasone) on T-cells of trained rats. |
BMC, C-dex, DEX |
| 22 |
1993 |
Effects of chicken anemia virus on cell-mediated immune function in chickens exposed to the virus by a natural route. |
PI |
| 23 |
1993 |
Enhanced chondrocyte destruction by lymphokine-activated killer cells. Possible role in rheumatoid arthritis. |
PMBC, RA, rIL-2 |
| 24 |
1993 |
Further characterization of an interleukin-2-like cytokine produced by Xenopus laevis T lymphocytes. |
IL-2, PHA |
| 25 |
1993 |
The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factor. |
Con A, rIL-2, TIL |
| 26 |
1993 |
Transforming growth factor beta (TGF beta) is produced by and influences the proliferative response of Xenopus laevis lymphocytes. |
IL-2, TGF-beta |
| 27 |
1992 |
A method for the analysis of biological transduction phenomena. |
Pb, PS/B |
| 28 |
1992 |
Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice. |
--- |
| 29 |
1992 |
Immune system activation associated with a naturally occurring infection in Xenopus laevis. |
--- |
| 30 |
1992 |
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma. |
IL-2, IL-4, LAK, TILs |
| 31 |
1991 |
Cellular interactions regulating the in vitro response of bovine lymphocytes to ovalbumin. |
FACS, mAbs, OA, TCR |
| 32 |
1991 |
Cervine T-lymphocyte growth factors and their measurement in tuberculosis. |
IL-2 |
| 33 |
1991 |
Effects of chicken anemia agent on lymphokine production and lymphocyte transformation in experimentally infected chickens. |
CAA, Con A, PI |
| 34 |
1991 |
Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis. |
MoAb, RA, TCR |
| 35 |
1991 |
Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni. |
IFN-gamma, IL, LN, NI, Th |
| 36 |
1991 |
Psychological status and immunological parameters of institutionalized aged. |
CDH, PHA |
| 37 |
1991 |
Regulation of mitogen- and TCGF-induced lymphocyte blastogenesis by prostaglandins and supernatant from equine embryos and endometrium. |
Con A, PGs, PHA |
| 38 |
1991 |
Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. |
TSTGF |
| 39 |
1991 |
Suppression by sorted CD8+CD11b- cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma. |
LAS, PBL |
| 40 |
1990 |
Blastogenic responses and production of TCGF by mononuclear cells isolated from the bovine endometrium. |
MNCs |
| 41 |
1990 |
Cellular basis of the proliferative response of human T cells to mouse xenoantigens. |
PBMC |
| 42 |
1990 |
Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma. |
EAL, rIL-2 |
| 43 |
1990 |
Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma. |
LAK, NK, rIL-2 |
| 44 |
1990 |
Immunosuppressive properties of follicular fluid from preovulatory horse follicles. |
--- |
| 45 |
1990 |
In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes. |
HPRT, PHA, TGr |
| 46 |
1990 |
Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. |
BSO, Con A, IL-2 |
| 47 |
1990 |
Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. |
LCL, NK |
| 48 |
1990 |
Production of bovine immunoregulatory molecules by xenogeneic hybrids. |
rhIL-2 |
| 49 |
1990 |
Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. |
GCs |
| 50 |
1990 |
Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. |
Con A, LN |
| 51 |
1989 |
Determination of in vivo and in vitro radiosensitivity of mouse splenic T-lymphocytes using a T-cell cloning technique. |
CEs |
| 52 |
1989 |
Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients. |
LAK, NK, PBL, rIL-2 |
| 53 |
1989 |
Heterogeneous lymphokine-activated killer cell precursor populations. Development of a monoclonal antibody that separates two populations of precursors with distinct culture requirements and separate target-recognition repertoires. |
LAK, mAb, NK, rIL-2 |
| 54 |
1989 |
Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma. |
LAK, LAS, PBL |
| 55 |
1989 |
Production and consumption of T cell growth factor by peripheral blood lymphocytes of cattle infected with Taenia saginata. |
Con A, IL-2, p.i, PBL |
| 56 |
1989 |
[Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers]. |
CTL, CTL, PBL |
| 57 |
1988 |
Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. |
PEL |
| 58 |
1988 |
Mechanisms of suppression in mixed allogeneic chimeras. |
NS, rIL-2, WBI |
| 59 |
1988 |
Participation of suppressor-inducer cells in the suppression of adjuvant arthritis by transfer of spleen cells expanded by T cell growth factor. |
AA, Con A |
| 60 |
1988 |
Production of human B and T cell growth factors is enhanced by thymic hormones. |
PBMC, T alpha 1, TF5 |
| 61 |
1988 |
Serum specifically potentiates the mitogenic response of Nb2 lymphoma cells to rat prolactin. |
--- |
| 62 |
1988 |
Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells. |
AET-SRBC, EC, PBMC |
| 63 |
1988 |
The ontogeny of interleukin production and responsivity in the frog, Xenopus. |
IL-1, LPS, PCs, PHA, SNs |
| 64 |
1987 |
A factor with interleukin-1-like activity is produced by peritoneal cells from the frog, Xenopus laevis. |
IL-1, LPS, PCs, PHA, SNs |
| 65 |
1987 |
Bovine helper T-cell clones specific for lymphocytes infected with Theileria parva (Muguga). |
MHC |
| 66 |
1987 |
Characterization of mouse thymocyte subpopulations by the enzymatic marker 20-alpha-hydroxysteroid dehydrogenase: differential responses to IL-1 and IL-2. |
20 alpha-SDH, Con A, IL-1, IL-2, PMA, rIL-1 |
| 67 |
1987 |
Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). |
GM-CSF, RP-HPLC |
| 68 |
1987 |
Human fetal lymphocytes require T cell growth factors for cytotoxic responses. |
MLC |
| 69 |
1987 |
Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient. |
HBV |
| 70 |
1987 |
Immunological studies in acquired immunodeficiency syndrome: effect of TCGF and indomethacine on the in vitro lymphocyte response. |
ARC, PBMC |
| 71 |
1987 |
Methods for the selection and growth of antigen-specific cytolytic T lines and clones bearing a defined T cell receptor beta chain marker. |
CTL, TCR |
| 72 |
1987 |
Mitogen-activated Xenopus laevis lymphocytes produce a T-cell growth factor. |
IL-2, PHA, SNs |
| 73 |
1987 |
Production and assay of ovine T cell growth factor by concanavalin A stimulated peripheral blood leukocytes. |
Con A |
| 74 |
1987 |
Quantitative assay of human T-cell leukemia/lymphoma virus transformation. |
HTLV-I |
| 75 |
1987 |
Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. |
HPRT, TG |
| 76 |
1987 |
Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. |
IL-2 |
| 77 |
1987 |
Regulation of T-cell functions by L-lactate. |
IL-1 |
| 78 |
1987 |
Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation. |
PHA |
| 79 |
1987 |
Transfer of spleen cells expanded by T cell growth factor suppresses arthritis induced in rats. |
AA, CIA, Con A |
| 80 |
1986 |
Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. |
IL-3, MCGF |
| 81 |
1986 |
Chicken T-cell growth factor: use in the generation of a long-term cultured T-cell line and biochemical characterization. |
Con A |
| 82 |
1986 |
Evaluation of lymphocytes' influence in luminol-dependent chemiluminescence emission of mouse spleen cells. |
CL, FA, KLH |
| 83 |
1986 |
Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. |
AIDS, Con A, MLC, PBMC, PHA, PPD, PWM |
| 84 |
1986 |
Mechanisms of transplantation tolerance in B-cell-chimeric chickens. Impairment of tolerance by T cell growth factor. |
GVH, MLR, PBL |
| 85 |
1986 |
Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma. |
NK |
| 86 |
1986 |
Serial transmission of human T-cell leukemia virus type I by blood transfusion in rabbits and its prevention by use of X-irradiated stored blood. |
HTLV-I |
| 87 |
1986 |
Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2. |
AFP, NK |
| 88 |
1986 |
T-cell involvement in benign phase chronic myelogenous leukemia. |
CML |
| 89 |
1986 |
The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor. |
--- |
| 90 |
1986 |
The induction of the human T-cell growth factor receptor precedes the production of RNA and occurs in the presence of inhibitors of RNA synthesis. |
AO, PHA, PY |
| 91 |
1986 |
[Interleukin-2 and cancer treatment]. |
CTL, IL-2, LAK |
| 92 |
1985 |
Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells. |
Con A, IL-2 |
| 93 |
1985 |
Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial. |
CPM, MLC |
| 94 |
1985 |
Cyclosporin A inhibits a discrete step in T-lymphocyte stimulation. |
CyA |
| 95 |
1985 |
Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay. |
ADCC, HTCA, LAK, PBL |
| 96 |
1985 |
Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines. |
APC, EGF, PDGF |
| 97 |
1985 |
Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer. |
PHA |
| 98 |
1985 |
Generation of human cytotoxic T lymphocytes against autologous solid tumors by autologous mixed lymphocyte tumor cell culture with T cell growth factor. |
CTL, MLTC |
| 99 |
1985 |
Generation of T cell growth factor (TCGF)- dependent splenic lymphoid cell line with cell-mediated immunosuppressive reactivity against syngeneic murine tumor. |
--- |
| 100 |
1985 |
HLA typing and karyotyping of limited numbers of lymphocytes is facilitated by in vitro expansion with TCGF. |
BM |
A Search Service for Abbreviation / Long Form
